The drug firm, however, did not provide any details of the contents of the warning letter received from the regulator.from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2J1Iwje
via IFTTT
Aurobindo Pharma gets warning letter from USFDA for Andhra Pradesh unit
The drug firm, however, did not provide any details of the contents of the warning letter received from the regulator.from Healthcare/Biotech-Industry-Economic Times http://bit.ly/2J1Iwje
via IFTTT
0 comments:
Post a Comment